Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)

NCT06788964 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Relapsed or Refractory Large B-cell Lymphoma

Interventions

DRUG: Loncastuximab Tesirine
DRUG: Rituximab

Sponsor

University of Utah

Collaborators

[object Object]